NCT00003103View on ClinicalTrials.gov

Chemotherapy in Treating Patients With Solid Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

August 31, 1997

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Bladder CancerBreast CancerColorectal CancerEsophageal CancerHead and Neck CancerKidney CancerLung CancerOvarian CancerProstate CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

oblimersen sodium

DRUG

docetaxel

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003103 - Chemotherapy in Treating Patients With Solid Tumors | Biotech Hunter | Biotech Hunter